Southborough, MA, United States of America

Rory A J Curtis

This inventor holds 25 USPTO granted patents and 1 published patent application, primarily in Protein Engineering. Top assignees: Millennium Pharmaceuticals Limited, Bayer Schering Pharma Ag, Bayer Corporation. Active years: 2002-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rory A J Curtis. Retrieved from https://idiyas.com/inventor/rory-a-j-curtis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 

% Patents Active = 28.0

Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Ashland, MA (US) (2009)
  • Framingham, MA (US) (2005 - 2010)
  • Southborough, MA (US) (2002 - 2012)

Company Filing History:


Years Active: 2002-2012

Loading Chart...
Areas of Expertise:
Capsaicin Receptors
Potassium Channels
Human Kinases
Nucleic Acids
Proteins
Phosphatases
Proteases
Agmatinase
Carboxylesterase
Transporter Proteins
Matrix Metalloproteinase
Eukaryotic Kinases
25 patents (USPTO):Explore Patents

Title: **Rory A J Curtis: Innovator in Capsaicin/Vanilloid Receptor Research**

Introduction

Rory A J Curtis is a distinguished inventor based in Southborough, MA, recognized for his significant contributions to the field of protein research. With an impressive portfolio of 25 patents, Curtis has made remarkable strides in the understanding and application of the capsaicin/vanilloid receptor family of proteins.

Latest Patents

Among his latest patents, Curtis’s work titled "Members of the capsaicin/vanilloid receptor family of proteins and uses thereof" stands out. This invention describes isolated nucleic acid molecules, designated hVR-1, hVR-2, and rVR-2, which encode novel members of the Capsaicin/Vanilloid receptor family. The patent elaborates on various components, including antisense nucleic acid molecules, recombinant expression vectors containing the mentioned nucleic acids, and host cells that have been genetically modified. Furthermore, it encompasses nonhuman transgenic animals with modified hVR-1, hVR-2, and rVR-2 genes. The invention also includes isolated proteins, fusion proteins, antigenic peptides, and specific antibodies, along with diagnostic methods that utilize the invention's compositions.

Career Highlights

Rory's career includes significant experiences at renowned organizations such as Millennium Pharmaceuticals Limited and Bayer Schering Pharma AG. His role in these companies has allowed him to translate complex scientific concepts into applicable innovations, furthering the advancement of biomedical research.

Collaborations

Collaboration has been a cornerstone of Curtis’s success, as evidenced by his work alongside esteemed colleagues like Rachel E Meyers and Rosana Kapeller-Libermann. These partnerships have fostered a collaborative environment that enhances research output and innovation in the field.

Conclusion

Rory A J Curtis exemplifies the spirit of innovation through his extensive research and patents related to the capsaicin/vanilloid receptors. His contributions highlight not only the importance of scientific exploration but also the collaborative efforts that drive advancements in medical science. With a continued focus on developing novel protein applications, Curtis remains a notable figure in the landscape of biotechnology and pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…